Induced Pluripotent Stem Cell (iPSC) Forecast Report – Designed for Decision Makers and Product Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#What Is the Growth Rate of the Induced Pluripotent Stem Cell (iPSC) Market?#_x000D_
The market size for induced pluripotent stem cells (iPSC) has been expanding swiftly in the past few years. The market is expected to progress from $3.3 billion in 2024 to $3.67 billion in 2025 with a compound annual growth rate (CAGR) of 11.3%. Numerous factors can explain the growth during the historical period including heightened healthcare spending, increased funding, greater awareness of the therapeutic benefits of stem cell products, use of iPSC in drug discovery, a surge in the demand for personalized medicine, as well as the cost-effectiveness of iPSC in drug discovery._x000D_
_x000D_
#What Growth Rate Is Forecasted for the Induced Pluripotent Stem Cell (iPSC) Market by 2029?#_x000D_
The market for induced pluripotent stem cell (iPSC) has a robust growth predicted in the next couple of years, with the expectation to expand to a whopping $5.29 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.6%. The factors contributing to this projected growth during the forecast period include the rise of chronic diseases, advancements in genomic projects, the creation of IPSC-derived disease models, the escalating increase of genetic diseases, government-led initiatives, and a swift progression in technology. The forecast period will also see significant trends including the creation of pluripotent stem cells for Parkinson’s disease (PD), strategic alliances and partnerships, the generation of induced pluripotent stem cell IPSC-derived NK cells, the use of induced pluripotent stem cell (iPSC) for cell therapy, funds allocated towards regenerative medicine research and development, the making of IPSC expansion medium, customized iPSC, and developing pluripotent stem cells for Type I diabetes._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp_x000D_
_x000D_
#Which Key Companies Are Shaping the Future of the Induced Pluripotent Stem Cell (iPSC) Market?#_x000D_
Major companies operating in the induced pluripotent stem cell (iPSC) market include FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio, Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, Takaria Bio, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, MSD, Pfizer, Roche, Pharmasyntez, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, GlaxoSmithKline, Parexel, Bayer, Fate Therapeutics, Athersys, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, VistaGen Therapeutics, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart_x000D_
_x000D_
#Which Factors Are Driving Demand in the Induced Pluripotent Stem Cell (iPSC) Industry?#_x000D_
The spike in rates of chronic illnesses plays a significant role in propelling the growth of the induced pluripotent stem cell industry. Induced pluripotent stem cells, which can be derived from tissues of either children or adults and genetically modified to mimic embryonic stem cells, can be used to treat diseases such as heart disease, cancer, stroke, and diabetes. A report by the Partnership to Fight Chronic Disorder (PFCD) disclosed that out of 133 million Americans, about 45% suffer from at least one chronic illness. Furthermore, it was projected that chronic diseases are responsible for 7 out of 10 deaths in the United States, which totals approximately 1.7 million deaths. These deaths could potentially be mitigated with induced pluripotent stem cell treatment. Consequently, the escalating prevalence of chronic illnesses is fuelling the demand for the induced pluripotent stem cell treatment market._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp_x000D_
_x000D_
#How Is the Induced Pluripotent Stem Cell (iPSC) Market Segmented by Several Divisions?#_x000D_
The induced pluripotent stem cell (iPSC) market covered in this report is segmented –_x000D_
_x000D_
1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types_x000D_
2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy_x000D_
3) By End-User: Hospitals, Research Laboratories_x000D_
_x000D_
Subsegments:_x000D_
1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies_x000D_
2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research_x000D_
3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies_x000D_
4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications_x000D_
5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research_x000D_
_x000D_
#What are the Emerging Market Trends Driving the Growth of the Induced Pluripotent Stem Cell (iPSC) Industry?#_x000D_
Firms in the Induced Pluripotent stem cell market are seeking strategic partnerships and collaborations to gain entry into new markets and broaden their product ranges. An instance of this was in January 2022, when Bristol Myers Squibb and Century Therapeutics decided upon a joint strategy to create IPSC-generated allogenic cell treatments targeting acute myeloid leukemia and multiple myeloma. Additionally, Evotec and Sernova revealed their alliance in May 2022, aimed at producing IPSC-based beta cell substitution therapy for curing type 1 and type 2 diabetes._x000D_
_x000D_
#Access The Full Report Here:#_x000D_
_x000D_
#Which Regions Are Driving Growth in the Induced Pluripotent Stem Cell (iPSC) Market?#_x000D_
North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2024. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (IPSC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
#Purchase The Full Report Today:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2515_x000D_
_x000D_
#This Report Delivers Insight On: #_x000D_
1. How big is the induced pluripotent stem cell (ipsc) market, and how is it changing globally?_x000D_
2. Who are the major companies in the induced pluripotent stem cell (ipsc) market, and how are they performing?_x000D_
3. What are the key opportunities and risks in the induced pluripotent stem cell (ipsc) market right now?_x000D_
4. Which products or customer segments are growing the most in the induced pluripotent stem cell (ipsc) market?_x000D_
5. What factors are helping or slowing down the growth of the induced pluripotent stem cell (ipsc) market?_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 2071930708_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
